Tafluprost (trade names Taflotan by Santen Pharmaceutical, Zioptan by Merck in the US and Saflutan by Mundipharma in Australia) is a prostaglandin analogue. It is used topically (as eye drops) to control the progression of open-angle glaucoma and in the management of ocular hypertension, alone or in combination with other medication. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes.
{{Drugbox | IUPAC_name = Isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate | image = Tafluprost_structure.svg | image_class = skin-invert-image
| tradename = Saflutan, Taflotan, Zioptan | Drugs.com = | pregnancy_AU = | pregnancy_category = | legal_AU = | legal_CA = Rx-only | legal_CA_comment = | legal_UK = | legal_US = Rx-only | legal_status = | routes_of_administration = Topical eye drops
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).